International Journal of Molecular Sciences · 2015 · 38 citations · 48 references
Life SciencesImmunologyOncologyCancer ImmunologyMetastasisTumor ImmunologyCancer ImmunosurveillanceCytokine BiologyImmune Evasion In MetastasisImmune ResponseInterferon ResponsesMelanocytic TumorsInterferon Gamma ResponseJak-stat Signaling In ImmunityJak-stat Signaling PathwayJanus Kinase-stat Signaling ActivationMajor Histocompatibility Complex SignalingMhc Class Ii MoleculesMhc Expression RegulationType Ii Interferon Response
Transcriptional activation of major histocompatibility complex (MHC) I and II molecules by the cytokine, interferon γ (IFN-γ), is a key step in cell-mediated immunity against pathogens and tumors. Recent evidence suggests that suppression of MHC I and II expression on multiple tumor types plays important roles in tumor immunoevasion. One such tumor is malignant melanoma, a leading cause of skin cancer-related deaths. Despite growing awareness of MHC expression defects, the molecular mechanisms by which melanoma cells suppress MHC and escape from immune-mediated elimination remain unknown. Here, we analyze the dysregulation of the Janus kinase (JAK)/STAT pathway and its role in the suppression of MHC II in melanoma cell lines at the radial growth phase (RGP), the vertical growth phase (VGP) and the metastatic phase (MET). While RGP and VGP cells both express MHC II, MET cells lack not only MHC II, but also the critical transcription factors, interferon response factor (IRF) 1 and its upstream activator, signal transducer and activator of transcription 1 (STAT1). Suppression of STAT1 in vitro was also observed in patient tumor samples, suggesting STAT1 silencing as a global mechanism of MHC II suppression and immunoevasion.
48
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
Edith M. Janssen, Edward E. Lemmens, Tom Wolfe et al. · Nature · 2003 · 1.6K citations
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Hirokazu Matsushita, Matthew D. Vesely, Daniel C. Koboldt et al. · Nature · 2012 · 1.3K citations · Full text
Medicine, Cancer Biology, Oncology +16
Sequence analysis of peptides bound to MHC class II molecules
Alexander Y. Rudensky, Paula Preston‐Hurlburt, Soon–Cheol Hong et al. · Nature · 1991 · 1.1K citations
Sergio A. Quezada, Tyler R. Simpson, Karl S. Peggs et al. · The Journal of Experimental Medicine · 2010 · 887 citations · Full text
Life Sciences, Immunology, Oncology +17
Tumor-specific Th17-polarized cells eradicate large established melanoma
Pawel Muranski, Andrea Boni, Paul A. Antony et al. · Blood · 2008 · 830 citations · Full text
Medicine, Immunology, Oncology +12